Dr. Rouven Westphal - Net Worth and Insider Trading

Dr. Rouven Westphal Net Worth

The estimated net worth of Dr. Rouven Westphal is at least $0 dollars as of 2025-05-16. Dr. Rouven Westphal is the Supervisory Board of SAP SE and owns about 0 shares of SAP SE (XTER:SAP) stock worth over $0. Details can be seen in Dr. Rouven Westphal's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dr. Rouven Westphal has not made any transactions after 2024-11-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Dr. Rouven Westphal

Dr. Rouven Westphal Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Dr. Rouven Westphal owns 1 companies in total, including SAP SE (XTER:SAP) .

Click here to see the complete history of Dr. Rouven Westphal’s form 4 insider trades.

Insider Ownership Summary of Dr. Rouven Westphal

Ticker	Company	Transaction Date	Type of Owner
XTER:SAP	SAP SE	2024-11-25	Supervisory Board

Dr. Rouven Westphal Latest Holdings Summary

Dr. Rouven Westphal currently owns a total of 1 stock. Dr. Rouven Westphal owns 0 shares of SAP SE (XTER:SAP) as of November 25, 2024, with a value of $0.

Latest Holdings of Dr. Rouven Westphal

Ticker	Company	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
XTER:SAP	SAP SE	2024-11-25	0	263.20	0

Holding Weightings of Dr. Rouven Westphal

Dr. Rouven Westphal Form 4 Trading Tracker

According to the SEC Form 4 filings, Dr. Rouven Westphal has made a total of 6 transactions in SAP SE (XTER:SAP) over the past 5 years, including 3 buys and 3 sells. The most-recent trade in SAP SE is the sale of 1,500 shares on November 25, 2024, which brought Dr. Rouven Westphal around $339,468.

Insider Trading History of Dr. Rouven Westphal

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Dr. Rouven Westphal Trading Performance

GuruFocus tracks the stock performance after each of Dr. Rouven Westphal's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dr. Rouven Westphal is -8.3%. GuruFocus also compares Dr. Rouven Westphal's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dr. Rouven Westphal within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Dr. Rouven Westphal's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Dr. Rouven Westphal

Average Return

Average return per transaction

Outperforming Transactions

1 out of 3 outperforming transactions.

Each transaction is measured over a period and compared to .

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Return(%)	-7.05
Relative Return to S&P 500(%)	-2.5

Dr. Rouven Westphal Ownership Network

Ownership Network List of Dr. Rouven Westphal

No Data

Ownership Network Relation of Dr. Rouven Westphal

Dr. Rouven Westphal Owned Company Details

What does SAP SE do?

Who are the key executives at SAP SE?

Dr. Rouven Westphal is the Supervisory Board of SAP SE. Other key executives at SAP SE include Supervisory Board Nicolas Sabatier , Supervisory Board Margret Klein-Magar , and Supervisory Board Gerhard Oswald .

SAP SE (XTER:SAP) Insider Trades Summary

Over the past 18 months, Dr. Rouven Westphal made 2 insider transaction in SAP SE (XTER:SAP) with a net sale of 5,000. Other recent insider transactions involving SAP SE (XTER:SAP) include a net sale of 948,396 shares made by Prof. Dr. h.c. mult. Hasso Plattner , a net sale of 3,140 shares made by Gerhard Oswald , and a net purchase of 981 shares made by Gina Vargiu-Breuer .

In summary, during the past 3 months, insiders sold 0 shares of SAP SE (XTER:SAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 957,653 shares of SAP SE (XTER:SAP) were sold and 2,401 shares were bought by its insiders, resulting in a net sale of 955,252 shares.

SAP SE (XTER:SAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

SAP SE Insider Transactions

No Available Data

Dr. Rouven Westphal Mailing Address

Above is the net worth, insider trading, and ownership report for Dr. Rouven Westphal. Currently GuruFocus does not have mailing address information for Dr. Rouven Westphal.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.